- Home
- SYRE vs PAM Comparison
SYRE vs PAM Comparison
Compare SYRE & PAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SYRE | PAM |
|---|---|---|
| Founded | 2013 | 1945 |
| Country | United States | Argentina |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.5B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | SYRE | PAM |
|---|---|---|
| Price | $64.21 | $83.55 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | $77.78 | ★ $94.50 |
| AVG Volume (30 Days) | ★ 898.2K | 240.7K |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $204,770.38 |
| Revenue Next Year | N/A | $16.65 |
| P/E Ratio | ★ N/A | $13.79 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.04 | $54.95 |
| 52 Week High | $75.00 | $94.50 |
Technical Indicators
Market Signals| Indicator | SYRE | PAM |
|---|---|---|
| Relative Strength Index (RSI) | 80.96 | 45.39 |
| Support Level | $15.23 | $82.87 |
| Resistance Level | N/A | $89.90 |
| Average True Range (ATR) | 4.11 | 3.01 |
| MACD | 1.44 | -0.31 |
| Stochastic Oscillator | 66.69 | 7.96 |
Price Performance
Historical ComparisonAbout SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About PAM Pampa Energia S.A.
Pampa Energia SA and its subsidiaries are engaged in the Energy business, mainly in oil and gas production and power generation. The firm's operating business segments are Oil and Gas, Generation, Petrochemicals, Holding, Transportation, and Others. The company derives the maximum revenue from the oil and gas segment.